Roche, Alzheimer's
An experimental Alzheimer’s therapy from Roche successfully cleared a protein that’s a hallmark of the disease from patients’ ...
The transaction, seen as a vote of confidence, has put the focus on other drug firms testing similar barrier-bridging ...
The treatment has the potential to cure diseases, but high costs and a difficult delivery process have held it back.
The CEO of pharmaceuticals giant Roche said authorities should block the takeover of contract drug manufacturer Catalent by ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Roche Holding AG (RHHVF – Research Report) and Pfizer (PFE – ...
After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...
Roche's key products like Vabysmo, Ocrevus, and Phesgo are performing well. Read why RHHBY stock looks well positioned to ...
The CEO of Roche said he has been informed that more cases of mpox infection have occurred in Europe than previously reported ...
Qure.ai partners with Roche Diagnostics APAC to develop AI-driven medical imaging technologies for healthcare innovation in ...
Roche revealed early-stage data for a new Alzheimer’s program on Wednesday as it seeks to jump back into a field littered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback